Format

Send to

Choose Destination
Int J Evid Based Healthc. 2015 Mar;13(1):9-18. doi: 10.1097/XEB.0000000000000020.

Validation of a new tool for the assessment of study quality and reporting in exercise training studies: TESTEX.

Author information

1
1University of New England, School of Science and Technology, Armidale, New South Wales, Australia 2Department of Translational Medical Sciences, Division of Internal Medicine and Cardiac Rehabilitation, Federico II University of Naples, Naples, Italy 3University of Leuven, KU Leuven, Department of Rehabilitation Sciences, Leuven, Belgium.

Abstract

INTRODUCTION:

Several established tools are available to assess study quality and reporting of randomized controlled trials; however, these tools were designed with clinical intervention trials in mind. In exercise training intervention trials some of the traditional study quality criteria, such as participant or researcher blinding, are extremely difficult to implement.

METHODS:

We developed the Tool for the assEssment of Study qualiTy and reporting in EXercise (TESTEX) - a study quality and reporting assessment tool, designed specifically for use in exercise training studies. Our tool is a 15-point scale (5 points for study quality and 10 points for reporting) and addresses previously unmentioned quality assessment criteria specific to exercise training studies.

RESULTS:

There were no systematic differences between the summated TESTEX scores of each observer [H(2)=0.392, P=0.822]. There was a significant association between the summated TESTEX scores of the three observers, with almost perfect agreement between observers 1 and 2 [intra-class correlation coefficient (ICC)=0.93, 95% confidence interval (CI) 0.82-0.97, P<0.001], observers 1 and 3 (ICC= 0.96, 95% CI 0.89-0.98, P<0.001) and observers 2 and 3 (ICC=0.91, 95% CI 0.75-0.96, P<0.001).

CONCLUSIONS:

The TESTEX scale is a new, reliable tool, specific to exercise scientists, that facilitates a comprehensive review of exercise training trials.

PMID:
25734864
DOI:
10.1097/XEB.0000000000000020
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center